APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lipid Nanoparticle (LNP) Formulation

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Lipid Nanoparticle (LNP) Formulation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

5 June 2026189 pages

Choose your research edition.

Industry ResearchLipid Nanoparticle (LNP) Formulation Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Lipid Nanoparticle (LNP) Formulation Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Lipid Nanoparticle (LNP) Formulation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lipid Nanoparticle (LNP) Formulation Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Lipid Nanoparticle (LNP) Formulation Market Analysis and Forecast 2026-2032189 pages · $4,950 USD

Market perspective

The global Lipid Nanoparticle (LNP) Formulation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Lipid Nanoparticle (LNP) Formulation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lipid Nanoparticle (LNP) Formulation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lipid Nanoparticle (LNP) Formulation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Lipid Nanoparticle (LNP) Formulation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Lipid Nanoparticle (LNP) Formulation include Precision NanoSystems (Cytiva), Ascendia Pharmaceuticals, CordenPharma, Evonik, Merck Millipore, Esco Aster, WuXi STA and Helix Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Lipid Nanoparticle (LNP) Formulation market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lipid Nanoparticle (LNP) Formulation and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lipid Nanoparticle (LNP) Formulation revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Lipid Nanoparticle (LNP) Formulation market size, projected growth trends, production technologies, key applications, and end-use industries.

Lipid Nanoparticle (LNP) Formulation Segment by Company

Precision NanoSystems (Cytiva)

Ascendia Pharmaceuticals

CordenPharma

Evonik

Merck Millipore

Esco Aster

WuXi STA

Helix Biotech

Lipid Nanoparticle (LNP) Formulation Segment by Type

mRNA-lipid Nanoparticle

siRNA-lipid Nanoparticle

Lipid Nanoparticle (LNP) Formulation Segment by Application

In Vitro and In Vivo Diagnostics

Medical Imaging

Nanotherapeutics

Vaccines

Regenerative Medicine

Lipid Nanoparticle (LNP) Formulation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lipid Nanoparticle (LNP) Formulation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lipid Nanoparticle (LNP) Formulation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lipid Nanoparticle (LNP) Formulation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Lipid Nanoparticle (LNP) Formulation in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lipid Nanoparticle (LNP) Formulation industry.

Chapter 3: Detailed analysis of Lipid Nanoparticle (LNP) Formulation companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lipid Nanoparticle (LNP) Formulationrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Lipid Nanoparticle (LNP) Formulation Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of mRNA-lipid Nanoparticle Table 3. Key Players of siRNA-lipid Nanoparticle Table 4. Global Lipid Nanoparticle (LNP) Formulation Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of In Vitro and In Vivo Diagnostics Table 6. Key Players of Medical Imaging Table 7. Key Players of Nanotherapeutics Table 8. Key Players of Vaccines Table 9. Key Players of Regenerative Medicine Table 10. Global Lipid Nanoparticle (LNP) Formulation Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Lipid Nanoparticle (LNP) Formulation Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Lipid Nanoparticle (LNP) Formulation Market Share by Region (2021-2026) Table 13. Global Lipid Nanoparticle (LNP) Formulation Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Lipid Nanoparticle (LNP) Formulation Market Share by Region (2027-2032) Table 15. Lipid Nanoparticle (LNP) Formulation Industry Trends Table 16. Lipid Nanoparticle (LNP) Formulation Industry Drivers Table 17. Lipid Nanoparticle (LNP) Formulation Industry Opportunities and Challenges Table 18. Lipid Nanoparticle (LNP) Formulation Industry Restraints Table 19. Global Lipid Nanoparticle (LNP) Formulation Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Lipid Nanoparticle (LNP) Formulation Revenue Market Share by Company (2021-2026) Table 21. Global Lipid Nanoparticle (LNP) Formulation Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Lipid Nanoparticle (LNP) Formulation Key Company Head Office and Area Served Table 23. Global Lipid Nanoparticle (LNP) Formulation Company, Product Type & Application Table 24. Global Lipid Nanoparticle (LNP) Formulation Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Lipid Nanoparticle (LNP) Formulation by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Lipid Nanoparticle (LNP) Formulation Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Lipid Nanoparticle (LNP) Formulation Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Lipid Nanoparticle (LNP) Formulation Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Lipid Nanoparticle (LNP) Formulation Revenue Market Share by Type (2021-2026) Table 31. Global Lipid Nanoparticle (LNP) Formulation Revenue Market Share by Type (2027-2032) Table 32. Global Lipid Nanoparticle (LNP) Formulation Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Lipid Nanoparticle (LNP) Formulation Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Lipid Nanoparticle (LNP) Formulation Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Lipid Nanoparticle (LNP) Formulation Revenue Market Share by Application (2021-2026) Table 36. Global Lipid Nanoparticle (LNP) Formulation Revenue Market Share by Application (2027-2032) Table 37. Precision NanoSystems (Cytiva) Company Information Table 38. Precision NanoSystems (Cytiva) Business Overview Table 39. Precision NanoSystems (Cytiva) Lipid Nanoparticle (LNP) Formulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Precision NanoSystems (Cytiva) Lipid Nanoparticle (LNP) Formulation Product Portfolio Table 41. Precision NanoSystems (Cytiva) Recent Development Table 42. Ascendia Pharmaceuticals Company Information Table 43. Ascendia Pharmaceuticals Business Overview Table 44. Ascendia Pharmaceuticals Lipid Nanoparticle (LNP) Formulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Ascendia Pharmaceuticals Lipid Nanoparticle (LNP) Formulation Product Portfolio Table 46. Ascendia Pharmaceuticals Recent Development Table 47. CordenPharma Company Information Table 48. CordenPharma Business Overview Table 49. CordenPharma Lipid Nanoparticle (LNP) Formulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. CordenPharma Lipid Nanoparticle (LNP) Formulation Product Portfolio Table 51. CordenPharma Recent Development Table 52. Evonik Company Information Table 53. Evonik Business Overview Table 54. Evonik Lipid Nanoparticle (LNP) Formulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Evonik Lipid Nanoparticle (LNP) Formulation Product Portfolio Table 56. Evonik Recent Development Table 57. Merck Millipore Company Information Table 58. Merck Millipore Business Overview Table 59. Merck Millipore Lipid Nanoparticle (LNP) Formulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Merck Millipore Lipid Nanoparticle (LNP) Formulation Product Portfolio Table 61. Merck Millipore Recent Development Table 62. Esco Aster Company Information Table 63. Esco Aster Business Overview Table 64. Esco Aster Lipid Nanoparticle (LNP) Formulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Esco Aster Lipid Nanoparticle (LNP) Formulation Product Portfolio Table 66. Esco Aster Recent Development Table 67. WuXi STA Company Information Table 68. WuXi STA Business Overview Table 69. WuXi STA Lipid Nanoparticle (LNP) Formulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. WuXi STA Lipid Nanoparticle (LNP) Formulation Product Portfolio Table 71. WuXi STA Recent Development Table 72. Helix Biotech Company Information Table 73. Helix Biotech Business Overview Table 74. Helix Biotech Lipid Nanoparticle (LNP) Formulation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Helix Biotech Lipid Nanoparticle (LNP) Formulation Product Portfolio Table 76. Helix Biotech Recent Development Table 77. North America Lipid Nanoparticle (LNP) Formulation Market Size by Type (2021-2026) & (US$ Million) Table 78. North America Lipid Nanoparticle (LNP) Formulation Market Size by Type (2027-2032) & (US$ Million) Table 79. North America Lipid Nanoparticle (LNP) Formulation Market Size by Application (2021-2026) & (US$ Million) Table 80. North America Lipid Nanoparticle (LNP) Formulation Market Size by Application (2027-2032) & (US$ Million) Table 81. North America Lipid Nanoparticle (LNP) Formulation Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 82. North America Lipid Nanoparticle (LNP) Formulation Market Size by Country (2021-2026) Table 83. North America Lipid Nanoparticle (LNP) Formulation Market Size by Country (2027-2032) Table 84. Europe Lipid Nanoparticle (LNP) Formulation Market Size by Type (2021-2026) & (US$ Million) Table 85. Europe Lipid Nanoparticle (LNP) Formulation Market Size by Type (2027-2032) & (US$ Million) Table 86. Europe Lipid Nanoparticle (LNP) Formulation Market Size by Application (2021-2026) & (US$ Million) Table 87. Europe Lipid Nanoparticle (LNP) Formulation Market Size by Application (2027-2032) & (US$ Million) Table 88. Europe Lipid Nanoparticle (LNP) Formulation Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. Europe Lipid Nanoparticle (LNP) Formulation Market Size by Country (2021-2026) Table 90. Europe Lipid Nanoparticle (LNP) Formulation Market Size by Country (2027-2032) Table 91. China Lipid Nanoparticle (LNP) Formulation Market Size by Type (2021-2026) & (US$ Million) Table 92. China Lipid Nanoparticle (LNP) Formulation Market Size by Type (2027-2032) & (US$ Million) Table 93. China Lipid Nanoparticle (LNP) Formulation Market Size by Application (2021-2026) & (US$ Million) Table 94. China Lipid Nanoparticle (LNP) Formulation Market Size by Application (2027-2032) & (US$ Million) Table 95. Asia Lipid Nanoparticle (LNP) Formulation Market Size by Type (2021-2026) & (US$ Million) Table 96. Asia Lipid Nanoparticle (LNP) Formulation Market Size by Type (2027-2032) & (US$ Million) Table 97. Asia Lipid Nanoparticle (LNP) Formulation Market Size by Application (2021-2026) & (US$ Million) Table 98. Asia Lipid Nanoparticle (LNP) Formulation Market Size by Application (2027-2032) & (US$ Million) Table 99. Asia Lipid Nanoparticle (LNP) Formulation Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. Asia Lipid Nanoparticle (LNP) Formulation Market Size by Country (2021-2026) Table 101. Asia Lipid Nanoparticle (LNP) Formulation Market Size by Country (2027-2032) Table 102. South America, Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Size by Type (2021-2026) & (US$ Million) Table 103. South America, Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Size by Type (2027-2032) & (US$ Million) Table 104. South America, Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Size by Application (2021-2026) & (US$ Million) Table 105. South America, Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Size by Application (2027-2032) & (US$ Million) Table 106. South America, Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. South America, Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Size by Country (2021-2026) Table 108. South America, Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Size by Country (2027-2032) Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Lipid Nanoparticle (LNP) Formulation Product Image Figure 2. Global Lipid Nanoparticle (LNP) Formulation Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Lipid Nanoparticle (LNP) Formulation Market Share by Type: 2025 VS 2032 Figure 4. mRNA-lipid Nanoparticle Image Figure 5. siRNA-lipid Nanoparticle Image Figure 6. Global Lipid Nanoparticle (LNP) Formulation Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Lipid Nanoparticle (LNP) Formulation Market Share by Application: 2025 VS 2032 Figure 8. In Vitro and In Vivo Diagnostics Image Figure 9. Medical Imaging Image Figure 10. Nanotherapeutics Image Figure 11. Vaccines Image Figure 12. Regenerative Medicine Image Figure 13. Global Lipid Nanoparticle (LNP) Formulation Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032) & (US$ Million) Figure 15. Global Lipid Nanoparticle (LNP) Formulation Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Lipid Nanoparticle (LNP) Formulation Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Lipid Nanoparticle (LNP) Formulation Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Lipid Nanoparticle (LNP) Formulation Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Lipid Nanoparticle (LNP) Formulation Revenue Market Share by Type (2021-2032) Figure 22. Global Lipid Nanoparticle (LNP) Formulation Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Lipid Nanoparticle (LNP) Formulation Revenue Market Share by Application (2021-2032) Figure 24. North America Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032) & (US$ Million) Figure 25. North America Lipid Nanoparticle (LNP) Formulation Market Share by Type (2021-2032) Figure 26. North America Lipid Nanoparticle (LNP) Formulation Market Share by Application (2021-2032) Figure 27. North America Lipid Nanoparticle (LNP) Formulation Market Share by Country (2021-2032) Figure 28. United States Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032) & (US$ Million) Figure 29. Canada Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032) & (US$ Million) Figure 31. Europe Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032) & (US$ Million) Figure 32. Europe Lipid Nanoparticle (LNP) Formulation Market Share by Type (2021-2032) Figure 33. Europe Lipid Nanoparticle (LNP) Formulation Market Share by Application (2021-2032) Figure 34. Europe Lipid Nanoparticle (LNP) Formulation Market Share by Country (2021-2032) Figure 35. Germany Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032) & (US$ Million) Figure 36. France Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032) & (US$ Million) Figure 38. Italy Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032) & (US$ Million) Figure 39. Russia Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032) & (US$ Million) Figure 41. China Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032) & (US$ Million) Figure 42. China Lipid Nanoparticle (LNP) Formulation Market Share by Type (2021-2032) Figure 43. China Lipid Nanoparticle (LNP) Formulation Market Share by Application (2021-2032) Figure 44. Asia Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032) & (US$ Million) Figure 45. Asia Lipid Nanoparticle (LNP) Formulation Market Share by Type (2021-2032) Figure 46. Asia Lipid Nanoparticle (LNP) Formulation Market Share by Application (2021-2032) Figure 47. Asia Lipid Nanoparticle (LNP) Formulation Market Share by Country (2021-2032) Figure 48. Japan Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032) & (US$ Million) Figure 52. India Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032) & (US$ Million) Figure 53. Australia Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Share by Country (2021-2032) Figure 58. Brazil Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032) & (US$ Million) Figure 63. UAE Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032) & (US$ Million) Figure 65. Chile Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • mRNA-lipid Nanoparticle
  • siRNA-lipid Nanoparticle
Applications
  • In Vitro and In Vivo Diagnostics
  • Medical Imaging
  • Nanotherapeutics
  • Vaccines
  • Regenerative Medicine
Companies covered
  • Precision NanoSystems (Cytiva)
  • Ascendia Pharmaceuticals
  • CordenPharma
  • Evonik
  • Merck Millipore
  • Esco Aster
  • WuXi STA
  • Helix Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Lipid Nanoparticle (LNP) Formulation Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 mRNA-lipid Nanoparticle
  5. 1.2.3 siRNA-lipid Nanoparticle
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Lipid Nanoparticle (LNP) Formulation Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 In Vitro and In Vivo Diagnostics
  9. 1.3.3 Medical Imaging
  10. 1.3.4 Nanotherapeutics
  11. 1.3.5 Vaccines
  12. 1.3.6 Regenerative Medicine
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Lipid Nanoparticle (LNP) Formulation Growth Trends by Region
  15. 1.5.1 Global Lipid Nanoparticle (LNP) Formulation Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Lipid Nanoparticle (LNP) Formulation Market Size by Region (2021-2026)
  17. 1.5.3 Lipid Nanoparticle (LNP) Formulation Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Lipid Nanoparticle (LNP) Formulation Market Dynamics
  1. 2.1 Lipid Nanoparticle (LNP) Formulation Industry Trends
  2. 2.2 Lipid Nanoparticle (LNP) Formulation Industry Drivers
  3. 2.3 Lipid Nanoparticle (LNP) Formulation Industry Opportunities and Challenges
  4. 2.4 Lipid Nanoparticle (LNP) Formulation Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Lipid Nanoparticle (LNP) Formulation Revenue by Company (2021-2026)
  2. 3.2 Global Lipid Nanoparticle (LNP) Formulation Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Lipid Nanoparticle (LNP) Formulation Key Company Head office and Area Served
  4. 3.4 Global Lipid Nanoparticle (LNP) Formulation Company, Product Type & Application
  5. 3.5 Global Lipid Nanoparticle (LNP) Formulation Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Lipid Nanoparticle (LNP) Formulation Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Lipid Nanoparticle (LNP) Formulation Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Lipid Nanoparticle (LNP) Formulation Tier 1, Tier 2, and Tier 3
4 Lipid Nanoparticle (LNP) Formulation Market by Type
  1. 4.1 Global Lipid Nanoparticle (LNP) Formulation Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Lipid Nanoparticle (LNP) Formulation Market Size by Type (2021-2032)
  3. 4.3 Global Lipid Nanoparticle (LNP) Formulation Market Size Share by Type (2021-2032)
5 Lipid Nanoparticle (LNP) Formulation Market by Application
  1. 5.1 Global Lipid Nanoparticle (LNP) Formulation Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Lipid Nanoparticle (LNP) Formulation Market Size by Application (2021-2032)
  3. 5.3 Global Lipid Nanoparticle (LNP) Formulation Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Precision NanoSystems (Cytiva)
  2. 6.1.1 Precision NanoSystems (Cytiva) Company Information
  3. 6.1.2 Precision NanoSystems (Cytiva) Business Overview
  4. 6.1.3 Precision NanoSystems (Cytiva) Lipid Nanoparticle (LNP) Formulation Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Precision NanoSystems (Cytiva) Lipid Nanoparticle (LNP) Formulation Product Portfolio
  6. 6.1.5 Precision NanoSystems (Cytiva) Recent Developments
  7. 6.2 Ascendia Pharmaceuticals
  8. 6.2.1 Ascendia Pharmaceuticals Company Information
  9. 6.2.2 Ascendia Pharmaceuticals Business Overview
  10. 6.2.3 Ascendia Pharmaceuticals Lipid Nanoparticle (LNP) Formulation Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Ascendia Pharmaceuticals Lipid Nanoparticle (LNP) Formulation Product Portfolio
  12. 6.2.5 Ascendia Pharmaceuticals Recent Developments
  13. 6.3 CordenPharma
  14. 6.3.1 CordenPharma Company Information
  15. 6.3.2 CordenPharma Business Overview
  16. 6.3.3 CordenPharma Lipid Nanoparticle (LNP) Formulation Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 CordenPharma Lipid Nanoparticle (LNP) Formulation Product Portfolio
  18. 6.3.5 CordenPharma Recent Developments
  19. 6.4 Evonik
  20. 6.4.1 Evonik Company Information
  21. 6.4.2 Evonik Business Overview
  22. 6.4.3 Evonik Lipid Nanoparticle (LNP) Formulation Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Evonik Lipid Nanoparticle (LNP) Formulation Product Portfolio
  24. 6.4.5 Evonik Recent Developments
  25. 6.5 Merck Millipore
  26. 6.5.1 Merck Millipore Company Information
  27. 6.5.2 Merck Millipore Business Overview
  28. 6.5.3 Merck Millipore Lipid Nanoparticle (LNP) Formulation Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Merck Millipore Lipid Nanoparticle (LNP) Formulation Product Portfolio
  30. 6.5.5 Merck Millipore Recent Developments
  31. 6.6 Esco Aster
  32. 6.6.1 Esco Aster Company Information
  33. 6.6.2 Esco Aster Business Overview
  34. 6.6.3 Esco Aster Lipid Nanoparticle (LNP) Formulation Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Esco Aster Lipid Nanoparticle (LNP) Formulation Product Portfolio
  36. 6.6.5 Esco Aster Recent Developments
  37. 6.7 WuXi STA
  38. 6.7.1 WuXi STA Company Information
  39. 6.7.2 WuXi STA Business Overview
  40. 6.7.3 WuXi STA Lipid Nanoparticle (LNP) Formulation Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 WuXi STA Lipid Nanoparticle (LNP) Formulation Product Portfolio
  42. 6.7.5 WuXi STA Recent Developments
  43. 6.8 Helix Biotech
  44. 6.8.1 Helix Biotech Company Information
  45. 6.8.2 Helix Biotech Business Overview
  46. 6.8.3 Helix Biotech Lipid Nanoparticle (LNP) Formulation Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Helix Biotech Lipid Nanoparticle (LNP) Formulation Product Portfolio
  48. 6.8.5 Helix Biotech Recent Developments
7 North America
  1. 7.1 North America Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032)
  2. 7.2 North America Lipid Nanoparticle (LNP) Formulation Market Size by Type
  3. 7.2.1 North America Lipid Nanoparticle (LNP) Formulation Market Size by Type (2021-2026)
  4. 7.2.2 North America Lipid Nanoparticle (LNP) Formulation Market Size by Type (2027-2032)
  5. 7.2.3 North America Lipid Nanoparticle (LNP) Formulation Market Share by Type (2021-2032)
  6. 7.3 North America Lipid Nanoparticle (LNP) Formulation Market Size by Application
  7. 7.3.1 North America Lipid Nanoparticle (LNP) Formulation Market Size by Application (2021-2026)
  8. 7.3.2 North America Lipid Nanoparticle (LNP) Formulation Market Size by Application (2027-2032)
  9. 7.3.3 North America Lipid Nanoparticle (LNP) Formulation Market Share by Application (2021-2032)
  10. 7.4 North America Lipid Nanoparticle (LNP) Formulation Market Size by Country
  11. 7.4.1 North America Lipid Nanoparticle (LNP) Formulation Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Lipid Nanoparticle (LNP) Formulation Market Size by Country (2021-2026)
  13. 7.4.3 North America Lipid Nanoparticle (LNP) Formulation Market Size by Country (2027-2032)
  14. 7.4.4 North America Lipid Nanoparticle (LNP) Formulation Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032)
  2. 8.2 Europe Lipid Nanoparticle (LNP) Formulation Market Size by Type
  3. 8.2.1 Europe Lipid Nanoparticle (LNP) Formulation Market Size by Type (2021-2026)
  4. 8.2.2 Europe Lipid Nanoparticle (LNP) Formulation Market Size by Type (2027-2032)
  5. 8.2.3 Europe Lipid Nanoparticle (LNP) Formulation Market Share by Type (2021-2032)
  6. 8.3 Europe Lipid Nanoparticle (LNP) Formulation Market Size by Application
  7. 8.3.1 Europe Lipid Nanoparticle (LNP) Formulation Market Size by Application (2021-2026)
  8. 8.3.2 Europe Lipid Nanoparticle (LNP) Formulation Market Size by Application (2027-2032)
  9. 8.3.3 Europe Lipid Nanoparticle (LNP) Formulation Market Share by Application (2021-2032)
  10. 8.4 Europe Lipid Nanoparticle (LNP) Formulation Market Size by Country
  11. 8.4.1 Europe Lipid Nanoparticle (LNP) Formulation Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Lipid Nanoparticle (LNP) Formulation Market Size by Country (2021-2026)
  13. 8.4.3 Europe Lipid Nanoparticle (LNP) Formulation Market Size by Country (2027-2032)
  14. 8.4.4 Europe Lipid Nanoparticle (LNP) Formulation Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032)
  2. 9.2 China Lipid Nanoparticle (LNP) Formulation Market Size by Type
  3. 9.2.1 China Lipid Nanoparticle (LNP) Formulation Market Size by Type (2021-2026)
  4. 9.2.2 China Lipid Nanoparticle (LNP) Formulation Market Size by Type (2027-2032)
  5. 9.2.3 China Lipid Nanoparticle (LNP) Formulation Market Share by Type (2021-2032)
  6. 9.3 China Lipid Nanoparticle (LNP) Formulation Market Size by Application
  7. 9.3.1 China Lipid Nanoparticle (LNP) Formulation Market Size by Application (2021-2026)
  8. 9.3.2 China Lipid Nanoparticle (LNP) Formulation Market Size by Application (2027-2032)
  9. 9.3.3 China Lipid Nanoparticle (LNP) Formulation Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032)
  2. 10.2 Asia Lipid Nanoparticle (LNP) Formulation Market Size by Type
  3. 10.2.1 Asia Lipid Nanoparticle (LNP) Formulation Market Size by Type (2021-2026)
  4. 10.2.2 Asia Lipid Nanoparticle (LNP) Formulation Market Size by Type (2027-2032)
  5. 10.2.3 Asia Lipid Nanoparticle (LNP) Formulation Market Share by Type (2021-2032)
  6. 10.3 Asia Lipid Nanoparticle (LNP) Formulation Market Size by Application
  7. 10.3.1 Asia Lipid Nanoparticle (LNP) Formulation Market Size by Application (2021-2026)
  8. 10.3.2 Asia Lipid Nanoparticle (LNP) Formulation Market Size by Application (2027-2032)
  9. 10.3.3 Asia Lipid Nanoparticle (LNP) Formulation Market Share by Application (2021-2032)
  10. 10.4 Asia Lipid Nanoparticle (LNP) Formulation Market Size by Country
  11. 10.4.1 Asia Lipid Nanoparticle (LNP) Formulation Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Lipid Nanoparticle (LNP) Formulation Market Size by Country (2021-2026)
  13. 10.4.3 Asia Lipid Nanoparticle (LNP) Formulation Market Size by Country (2027-2032)
  14. 10.4.4 Asia Lipid Nanoparticle (LNP) Formulation Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst